Personalized Medicine and Anti-EGFR Antibody Therapy in the Treatment of Metastatic Colorectal Cancer: KRAS and Beyond

被引：0
|
作者：
Chu, Edward [1 ]
机构：
[1] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15260 USA
来源：
ONCOLOGY-NEW YORK | 2014年 / 28卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：96 / 96
页数：1
相关论文
共 50 条
  • [1] Beyond KRAS status and response to anti-EGFR therapy in metastatic colorectal cancer
    Perkins, Geraldine
    Pilati, Camilla
    Blons, Helene
    Laurent-Puig, Pierre
    PHARMACOGENOMICS, 2014, 15 (07) : 1043 - 1052
  • [2] EGFR and KRAS mutations during anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer: Clinically relevant?
    Karayan-Tapon, Lucie
    Ferru, Aurelie
    Cortes, Ulrich
    Villalva, Claire
    Tourani, Jean Marc
    Silvain, Christine
    Levillain, Pierre
    Tougeron, David
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [3] OUTCOME OF ANTI-EGFR ANTIBODY THERAPY IN METASTATIC COLORECTAL CANCER WITH LOW-FREQUENCY KRAS MUTATIONS
    Hikosaka, T.
    Yamazaki, K.
    Tsushima, T.
    Todaka, A.
    Yokota, T.
    Machida, N.
    Fukutomi, A.
    Onozawa, Y.
    Nakajima, T.
    Yasui, H.
    ANNALS OF ONCOLOGY, 2013, 24
  • [4] Beyond KRAS:Predictive factors of the efficacy of anti-EGFR monoclonal antibodies in the treatment of metastatic colorectal cancer
    Alfonso De Stefano
    Chiara Carlomagno
    World Journal of Gastroenterology, 2014, (29) : 9732 - 9743
  • [5] Beyond KRAS: Predictive factors of the efficacy of anti-EGFR monoclonal antibodies in the treatment of metastatic colorectal cancer
    De Stefano, Alfonso
    Carlomagno, Chiara
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (29) : 9732 - 9743
  • [6] KRAS mutation testing in the treatment of metastatic colorectal cancer with anti-EGFR therapies
    Soulieres, D.
    Greer, W.
    Magliocco, Anthony M.
    Huntsman, D.
    Young, S.
    Tsao, M-S.
    Kamel-Reid, S.
    CURRENT ONCOLOGY, 2010, 17 : S31 - S40
  • [7] The secondary mutation of KRAS and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer
    Xia, X.
    Du, W.
    Zhu, Y.
    Bai, Y.
    Liu, M.
    CLINICAL & EXPERIMENTAL METASTASIS, 2017, 34 (3-4) : 218 - 218
  • [8] The pathologist's involvement in anti-EGFR antibody therapy in metastatic colorectal cancer
    Sacoun, Esther
    ANNALES DE PATHOLOGIE, 2010, 30 (04) : VII - X
  • [9] Mechanisms of resistance to anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer
    Zacharenia Saridaki
    Vassilis Georgoulias
    John Souglakos
    World Journal of Gastroenterology, 2010, 16 (10) : 1177 - 1187
  • [10] Mechanisms of resistance to anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer
    Saridaki, Zacharenia
    Georgoulias, Vassilis
    Souglakos, John
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (10) : 1177 - 1187
12345